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S troke is a devastating complication of both coronaryartery bypass grafting (CABG) surgery and percutaneous
coronary intervention (PCI). In a recent survey of 3112 cardiac
patients by Sun and colleagues, death or prolonged hospital-
ization and long-term disability due to stroke was identiﬁed as
the main concerns of patients undergoing invasive proce-
dures.1 Better understanding of the prevalence of stroke and
its acute and long-term sequelae by both physicians and
patients may have important implications for the choice of a
particular revascularization strategy.
Surgical revascularization carries a higher procedural risk
of stroke than PCI.2 However, CABG may offer better long-
term survival in certain subsets of patients. Advancements in
surgical techniques, medical therapy optimization, and neu-
rologic risk stratiﬁcation as well as in stent technology and
pharmacological treatment continue to improve outcomes, so
comparisons are often generally outdated soon after guideline
recommendations are made. This speed adds to the chal-
lenges that patients, who are likely to prefer a less invasive
approach, and physicians need to deal with in their decision
process.
In this review, we summarize the current evidence on the
incidence, pathogenesis, and outcomes of stroke after CABG
and PCI. Moreover, we provide strategies on how to reduce
the risk of stroke with both types of revascularization and
relevant potentially preventative measures for use in daily
practice.
Search Methods
Because this article is an expert review and not a systematic
review, no systematic search was performed and the PRISMA
(Preferred Reporting Items for Systematic Reviews and Meta-
analyses) guidelines were not followed.
In November 2018 a comprehensive search was performed
to identify studies examining risk factors, incidence, patho-
genesis, and outcomes of periprocedural stroke in the setting
of CABG and PCI; studies evaluating strategies aimed at
minimizing neurological risk in both settings were also
included. The following databases were searched from
inception to the present: Ovid Medline, Ovid Embase, and
the Cochrane Library (Cochrane Database of Systematic
Reviews, Cochrane Central Register of Controlled Trials, and
Cochrane Methodology Register).
Search keywords included stroke in combination with
CABG, myocardial revascularization, coronary artery bypass,
PCI, and percutaneous coronary interventions. Relevant
abstracts were reviewed, and the “related articles” function
was used for all included papers. References for all selected
studies were crosschecked. The writing groups selected the
most relevant papers according to both methodological and
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clinical considerations. Observational series were considered
only in the absence of data from randomized controlled trials
(RCTs).
Risk Factors and Incidence of Periprocedural
Stroke
Coronary Artery Bypass Grafting
According to the Society of Thoracic Surgeons CABG Adult
Cardiac Surgery Database (STS ACSD), the incidence of
stroke after CABG is 1.3%, with a decrease from 1.6% to 1.2%
between 2000 and 2009.3 The most important risk factors for
stroke are age, dialysis dependency, severe chronic lung
disease, emergency surgery, and atherosclerotic burden in the
coronary artery and other vascular beds.4,5 Based on large
single-center studies and the most recent data from the STS
ACSD, the perioperative mortality for patients who had a
stroke after CABG is close to 20%.6,7
Percutaneous Coronary Intervention
In observational PCI series, the risk of stroke, both ischemic and
hemorrhagic, ranges between 0.2% and 0.5% (Table 1).8–12 The
incidence of ischemic stroke is generally 3-fold higher com-
pared with hemorrhagic stroke.8 The rates of ischemic stroke
appear to have slightly increased in recent years, most likely
because of the increasing complexity of the patients. Con-
versely, hemorrhagic stroke rates have decreased, probably as
a consequence of reduced use of thrombolytics and stricter
monitoring of anticoagulation.8
Independent predictors of periprocedural stroke include
older age, history of prior stroke, acute coronary syndrome
(ACS), and use of an intra-aortic balloon pump (IABP;
Table 1).8–11 It has been estimated that the risk of peripro-
cedural ischemic stroke increases by 35% for each
additional point in the CHA2DS2-VASc score.
13
CABG Versus PCI
An individual patient data meta-analysis of 11 trials of 11 518
patients randomized to CABG versus PCI reported a signiﬁ-
cantly higher rate of stroke at 5-year follow-up after CABG
(3.2% in the CABG arm versus 2.6% in the PCI arm; hazard
ratio [HR]: 1.23; 95% CI, 1.03–1.39). The differential in stroke
rate was driven by a reduced risk of stroke with PCI (0.4%)
versus CABG (1.1%) in the 30-day postprocedural period (HR:
1.67; 95% CI, 1.47–1.80) but a similar risk of stroke between
31 days and 5 years (HR: 0.95; 95% CI, 0.62–1.20; Figure 1).
Of note, the greater risk of stroke after CABG was most
evident in patients with a heavy atherosclerotic burden and
diabetes mellitus.14
In an 11-year statewide analysis from New Jersey
comparing different revascularization strategies, on-pump
CABG had a higher risk of stroke compared with off-pump
CABG (odds ratio [OR]: 1.36; 95% CI, 1.18–1.56), although
off-pump CABG still had a higher risk of stroke than
PCI with drug-eluting stents (OR: 1.36; 95% CI, 1.26–
1.45).10
Regardless of the speciﬁc setting (CABG or PCI), it should
be noted that when a neurologist is directly involved in the
determination, diagnostic accuracy for stroke (and thus its
incidence) can be higher compared with patients who are
assessed by other clinicians (ie, nonneurologists, who are
more likely to miss subtle strokes).15–18
Timing and Pathogenesis of Periprocedural
Stroke
Coronary Artery Bypass Grafting
An analysis of stroke after 45 432 CABG procedures reported
that the risk of stroke peaked at postoperative day 2 (0.6%
cumulative incidence) and stabilized to a constant hazard
after the ﬁrst postoperative week (0.8% cumulative incidence)
up to 30 days.7 In the above-mentioned individual patient-
data meta-analysis, the risk of stroke remained constant after
30 days up to 5-year follow-up.14 Because the risk of stroke
after CABG evolves during follow-up, it is important to assess
the etiology in 3 distinct time periods (Table 2): (1) intraop-
erative, (2) early postoperative (ﬁrst 7 days), and (3) late
(beyond 7 days) phases.19–22
Intraoperative stroke
Thromboembolism and hypoperfusion are the main etiologies
of stroke during the procedure or in the immediate postop-
erative period, with studies reporting that 60% are throm-
boembolic and 40% are due to hypoperfusion; hemorrhagic
strokes are uncommon.23–25
Thromboembolism may arise from aortic, cardiac, or
cardiopulmonary bypass sources. Manipulation of the aorta
occurs during cannulation, cross-clamping, and proximal
anastomosis of a conduit. Atherosclerosis of the ascending
aorta is documented in >50% of patients undergoing CABG,
and surgical manipulation can cause dislodgement of
atheroma or calcium.26,27 Studies examining intra-aortic
embolic ﬁlters demonstrate that particulate emboli are
frequent during CABG, especially at the time of placement
or removal of the aortic cross-clamp.28,29 Doppler detection
of microembolic signals is higher at the start of cardiopul-
monary bypass, and at the time of aortic clamping and
unclamping.30
Bilateral watershed strokes are found signiﬁcantly more
often after cardiac surgery than in the general population. One
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study evaluated 98 patients with postoperative stroke and
found that bilateral watershed strokes were diagnosed in 48%
of magnetic resonance imaging and 22% of computed
tomography (CT) scans.31 A decrease in mean arterial
pressure of ≥10 mm Hg was an important predictor of
watershed strokes (OR: 4.06; 95% CI, 1.03–15.98). Although
hypoperfusion has been implicated in postoperative neuro-
logical dysfunction, elevated mean arterial pressure may also
be associated with postoperative delirium and stroke.32
Patients with severe carotid artery disease have a higher risk
of stroke when hypoperfusion occurs during surgery, but it is
still largely accepted that CABG is safe in most patients with
carotid artery disease; the role of systematic preoperative
carotid screening is still debated.33
Early postoperative stroke
The majority of strokes related to CABG occur during the ﬁrst
7 postoperative days and are related to arrhythmias and
hemodynamic instability. Postoperative atrial ﬁbrillation
(POAF) occurs in up to 30% of CABG patients before hospital
discharge and is a signiﬁcant predictor of stroke.34–36 One
study reported that stroke was preceded by POAF in about a
third of patients, with a mean time of 21 hours.36 Other
thromboembolic causes of stroke are less common during
this period, although theoretically, intraoperative aortic
manipulation (cannulation, cross-clamping sites, and proximal
anastomoses) may still generate embolic clots that result in a
delayed neurological event. Of note, residual effects of
anesthesia may delay the recognition of intraoperative
strokes during the early postoperative period.
Low cardiac output syndrome is an important predictor of
stroke through hypoperfusion.37,38 One study of 11 825
patients found that low cardiac output syndrome and the need
for prolonged use of inotropes increased the risk of stroke
with ORs of 3 and 5, respectively.38 Another factor that may
be related to stroke is postoperative bleeding, associated with
hypoperfusion by hypovolemia and often anemia.
Late stroke
Late stroke is largely predicted by the overall atherosclerotic
risk proﬁle of patients, with risk increased in older patients,
patients who have previously had a stroke, or those with
hypertension, hypercholesterolemia, diabetes mellitus, or
peripheral vascular disease.39,40 POAF after CABG is an
important contributor to the risk of stroke during long-term
follow-up.41 A meta-analysis reported that the risk of stroke in
patients with POAF remained signiﬁcantly higher during a
median follow-up of 2 years compared with patients without
POAF.42 Nevertheless, the long-term risk of stroke associated
with new-onset POAF appears to be smaller than the risk
associated with nonvalvular atrial ﬁbrillation.
Percutaneous Coronary Intervention
In the ﬁrst weeks after PCI, there is an early peak in the risk of
stroke, followed by a gradual decline. In a nationwide PCI
registry from Norway, the relative risk of stroke was highest
during the ﬁrst 48 hours (relative risk: 17.5; 95% CI, 4.2–
72.8) and then decreased gradually, with a relative risk of 2.0
(95% CI, 1.2–3.3) at 4 to 8 weeks after PCI.43
Table 1. Incidence and Predictors of Periprocedural Stroke in Large (N>10 000) Unselected Series of PCI
Study Year Patients (N) Incidence of Stroke Mortality Rates Predictors
Aggarwal et al11 2004–2007 706 782 Periprocedural: 0.22% In-hospital: 30%
(any stroke) vs 1%
(no stroke)
Known CVD, older age,
ACS, IABP use
Werner et al9 2005–2008 46 888 Periprocedural: 0.4% In-hospital: 19.2%
(any stroke) vs 1.3%
(no stroke)
Hemodynamic instability,
older age, history of
stroke, congestive
heart failure, graft
PCI, renal failure
Kwok et al8 2007–2012 426 046 Periprocedural: 0.13% 30-d: 16%
(ischemic stroke/TIA)
vs 48% (hemorrhagic
stroke) vs 2% (no stroke)
Ischemic: older age,
male gender, prior
stroke, prior VHD, IABP
use, thrombus
aspiration, ACS
Hemorrhagic: age,
VHD, ACS, warfarin
use, thrombolysis
Moreyra et al10 2002–2012 115 942 Periprocedural: 0.48% NR NR
ACS indicates acute coronary syndrome; CVD, cerebrovascular disease; IABP, intra-aortic balloon pump; NR, not reported; PCI, percutaneous coronary intervention; TIA, transient ischemic
attack; VHD, valvular heart disease.
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Figure 1. Comparison of CABG and PCI for stroke during 5-year follow-up (A) and in landmark analyses of
stroke at and beyond 30 days (B). HRs are for PCI vs CABG. Reprinted from Head et al14 with permission.
Copyright ©2018, Elsevier. CABG indicates coronary artery bypass grafting; HR, hazard ratio; PCI,
percutaneous coronary intervention.
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The possible mechanisms of periprocedural stroke after
PCI are summarized in Figure 2. In a retrospective study of 35
patients with radiologically conﬁrmed ischemic stroke occur-
ring after PCI, the majority of strokes (91%) were embolic,
typically at the level of the middle cerebral artery territory.44
Dislodgement of atherosclerotic debris or other material from
the aorta may occur from manipulation of wires and catheters
during the cannulation of the coronary ostia. Intuitively, this
theoretical risk is enhanced in the context of tortuous
anatomies.
In a meta-analysis of 3 RCTs comparing manual thrombec-
tomy and PCI alone in ST-segment–elevation myocardial
infarction, stroke or transient ischemic attack occurred more
frequently in patients randomized to thrombus aspiration,
although the difference was not statistically signiﬁcant.45 The
increased risk of stroke with manual thrombectomy is
probably related to embolization of debris or fragments of
thrombus.46
The risk of embolization is greater when larger devices,
such as an IABP, are used. In a meta-analysis of 33 studies
involving 18 889 patients, the risk of stroke was signiﬁcantly
increased when an IABP was used (OR: 1.71; 95% CI, 1.04–
2.82).47 Of note, in a relatively small trial of hemodynamic
support for complex PCI with the Impella 2.5 (Abiomed) or
IABP, the incidence of stroke or transient ischemic attack at
30 days was lower in patients supported by Impella 2.5
(P=0.04).48 The mechanism of cerebrovascular events with
these support devices is not fully elucidated and may be
attributed to confounders in light of the increased risk proﬁle
of these patients.
Additional causes of periprocedural stroke include air
embolism, hypo- or hypertension, arrhythmias, and arterial
dissection.49,50 Aggressive antiplatelet or anticoagulant treat-
ment regimens may increase the risk of hemorrhagic stroke.8
Finally, atrial ﬁbrillation is an important contributor to the risk
of stroke even after PCI,51 although it is much less common
than after CABG.41
The risk of ischemic and hemorrhagic stroke continues to
increase steadily during follow-up related to nonprocedural
factors but does not exceed the risk observed in patients with
stable coronary artery disease who did not undergo PCI.52
CABG Versus PCI
In the SYNTAX (Synergy Between Percutaneous Coronary
Intervention With Taxus and Cardiac Surgery) trial, stroke was
more common after CABG than after PCI; however, a third of
the periprocedural strokes occurred before the index proce-
dure, presumably related to the discontinuation of dual-
antiplatelet therapy (DAPT) in patients randomized to surgical
revascularization.39
In their patient-level meta-analysis of RCTs comparing
CABG and PCI, Head and colleagues conﬁrmed that the
highest rate of stroke occurred within the ﬁrst 7 to 10 days
after CABG. After the initial intra- and early postoperative
periods, stroke rates after CABG and PCI were similar (2.2%
versus 2.1%), and the risk of stroke remained low during 5-
year follow-up.14
In a post hoc analysis of the EXCEL (Evaluation of XIENCE
versus Coronary Artery Bypass Surgery for Effectiveness of Left
Main Revascularization) trial, patients with known cerebrovas-
cular disease had had higher rates of stroke at 30 days (2.2%
versus 0.8%; P=0.05) and 3 years (6.4% versus 2.2%; P=0.0003)
compared with patients without cerebrovascular disease,
independent of treatment modality.53
Effect of Periprocedural Stroke on Short- and
Long-Term Survival and Quality of Life
Coronary Artery Bypass Grafting
In a large single-institution study of >45 000 patients with a
mean follow-up of 11 years, patients who experienced a
perioperative stroke had 37% 10-year survival compared with
68% of patients who did not have stroke (P<0.001 even after
adjustment).7 Among 5971 patients undergoing cardiac
surgery at Johns Hopkins Hospital (3974 CABG), stroke was
diagnosed in 214 (3.6%). Survival of stroke patients was 67%
Table 2. Stroke Etiology in the Intraoperative, Early Postoperative (First 7 Days), and Late (>7 Days) Phases After CABG
Timing CABG
Intraoperative 1. Thromboembolic: (a) macroembolism from atherosclerotic aorta; (b) cardiac etiology; (c) air embolism
2. Cerebral hypoperfusion: (a) low mean arterial pressure; (b) carotid stenosis; (c) cerebral atherosclerosis
Early postoperative 1. Atrial fibrillation: (a) new-onset postoperative; (b) preexisting chronic
2. Low cardiac output syndrome
3. Bleeding
Late 1. Thromboembolic: (a) atherosclerotic risk profile; (b) atrial fibrillation
2. Repeat revascularization procedures
CABG indicates coronary artery bypass grafting.
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at 1 year and 47% at 5 years, and long-term disability was
moderate to severe in 69%. Of note, stroke patients who
carried the diagnosis of previous stroke were much less likely
to be discharged directly home (22.2% versus 50.3%), and
patients who demonstrated acute watershed infarction on
brain imaging were half as likely to be discharged directly
home (22.2% versus 51.4%) than those without watershed
infarction.54
Percutaneous Coronary Intervention
Both periprocedural ischemic and hemorrhagic strokes have
high mortality (Table 1).8–11 In the National Cardiovascular
Data Registry, in-hospital mortality was 30% for patients who
developed a stroke compared with 1% for those without
stroke.11 In the PCI registry of the Euro Heart Survey Program,
overall in-hospital mortality was 19.2% for patients who
developed stroke compared with 1.3% for those without
stroke.9 In the British Cardiovascular Intervention Society
(BCIS) database, ischemic stroke was independently associ-
ated with 30-day mortality (OR: 4.92; 95% CI, 3.06–7.92) and
an even greater impact on prognosis was observed with
hemorrhagic stroke (OR: 13.87; 95% CI, 6.37–30.21).8 More
than half of patients who have a PCI-related stroke are left
with a neurological deﬁcit, and a quarter need skilled home
assistance.55 In the above-mentioned individual patient-data
pooled analysis of 11 RCTs, PCI patients who experienced a
stroke had signiﬁcantly higher 5-year mortality compared with
those without a stroke (45.7% versus 11.1%, P<0.001).14
The prognostic impact of periprocedural stroke on early
mortality may also depend on the clinical presentation. An
analysis of 560 439 PCI patients from the BCIS database
documented an adjusted OR of 37.9 for 30-day mortality after
elective PCI (unadjusted crude rate: 13% versus 0.3%) and an
adjusted OR of 5.0 for PCI in the context of an ACS
(unadjusted crude rate: 27% versus 3%).56
CABG Versus PCI
Beyond periprocedural mortality, stroke after either CABG or
PCI carries a 4-fold increase in all-cause mortality at
5 years.14 In the SYNTAX trial, although no signiﬁcant
difference was noted between CABG (3.7%) and PCI (2.4%)
in the cumulative incidence of stroke at 5 years, the majority
of patients who had a stroke either died (10% of patients with
stroke after CABG; 16% after PCI) or had long-term residual
Figure 2. Mechanism of stroke during and immediately after PCI. IABP indicates intra-aortic balloon
pump; PCI, percutaneous coronary intervention.
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impairment (68% of patients with stroke after CABG; 47% after
PCI).39
At 5 years, patients enrolled in the PRECOMBAT (Premier
of Randomized Comparison of Bypass Surgery versus
Angioplasty Using Sirolimus-Eluting Stent in Patients with
Left Main Coronary Artery Disease) trial who experienced a
stroke within 30 days of the procedure had signiﬁcantly
higher mortality versus those without a stroke, after both PCI
(45.7% versus 11.1%) and CABG (41.5% versus 8.9%).57 An 11-
year statewide analysis from New Jersey reported that for
both CABG and PCI, the occurrence of postprocedural stroke
was associated with increased 30-day and 1-year mortality.10
Strategies to Minimize the Neurological Risk
in CABG and PCI
Coronary Artery Bypass Grafting
Possible measures to reduce emboli include intra-operative
epiaortic scanning, preoperative CT scanning, and the use of
single cross-clamp techniques,26,27 although the level of
evidence supporting these approaches is low.33,58 Several
investigations have proven the superior sensitivity of
epiaortic scanning over both transesophageal echocardiog-
raphy and surgical palpation for accurate assessment of
ascending aortic atherosclerosis59; accordingly, international
guidelines recommend epiaortic ultrasound before aortic
manipulation “to identify atheromatous plaques and select
the optimal surgical strategy” (class of recommendation IIa,
level of evidence C).33 Zingone and colleagues assessed the
impact of epiaortic scanning on the incidence of perioper-
ative stroke in 2172 patients undergoing cardiac surgery. In
the CABG cohort, perioperative stroke rates were 3.4%,
0.5%, and 1.7% in the no-scan, selective-scan (high-risk
patients only), and regular-scan groups, respectively
(P=0.002), with no substantial change following risk adjust-
ment.60
As opposite to epiaortic scanning, pre-operative CT offers
the advantage of identifying high-risk patients and allowing
discussion of alternate strategies before sternotomy is
performed. CT scan was used by Lee and coworkers to
preoperatively assess 114 cardiac surgery patients at high
risk for stroke; signiﬁcant calciﬁcations in the ascending aorta
were found in 20 of these, leading to alteration of surgical
strategy in 19 cases. Of note, the authors reported stroke
rates of 3.04% and 0.73% in the pre- and post-CT period,
respectively (P=0.05).61
A recent multicenter RCT enrolled 383 patients undergoing
surgical aortic valve replacement to evaluate the potential
neuroprotective role of 2 cannulation systems designed to
capture aortic microemboli (Embol-X embolic protection
device [Edwards Life Science] and CardioGard cannula). Rate
of freedom from cerebral infarction at 7 days was 32.0%
versus 33.3% for suction-based extraction versus control (ie,
standard aortic cannula), respectively (between-group differ-
ence: 1.3%; 95% CI, 13.8% to 11.2%) and 25.6% versus
32.4% for intra-aortic ﬁltration versus control, respectively
(between-group difference: 6.9%; 95% CI, 17.9% to 4.2%);
no signiﬁcant differences in mortality or clinical stroke were
shown.62
Off-pump surgery reduces the amount of aortic manipula-
tion by avoiding cannulation and cross-clamping. However,
RCTs have not demonstrated a difference in the risk of
procedure-related stroke after on- versus off-pump CABG; in a
small randomized trial, early brain magnetic resonance
imaging showed no signiﬁcant differences in acute cerebral
infarctions between on- and off-pump CABG.63 Conversely, a
meta-analysis (consisting of mostly observational studies)
found that on-pump CABG was associated with an increased
incidence of stroke in comparison to off-pump CABG.64 In
addition, a review of a national administrative database
associated off-pump surgery with a signiﬁcant reduction in
stroke rates compared with on-pump surgery in patients aged
≥80 years, those with peripheral vascular disease, and those
with aortic atherosclerosis.65 The lack of difference in stroke
rate between off- and on-pump techniques in RCTs has been
attributed to aortic manipulation required for the use of lateral
side clamps for proximal anastomoses during off-pump CABG.
Anaortic CABG is a technique aimed at avoiding any degree
of aortic manipulation during surgery by using complex in situ
graft conﬁgurations and off-pump techniques.66 A recent
network meta-analysis compared different degrees of aortic
manipulation from on-pump CABG with single or multiple
aortic clamps and found that anaortic CABG versus traditional
on-pump CABG signiﬁcantly reduced stroke risk (OR: 0.22;
95% CI, 0.14–0.33).67 Similar results were reported in a large
single-center study of >13 000 patients.68 This technique,
however, is technically challenging and there is a learning
curve, so superspecialization in complex CABG is being
advocated by some.66,69 It should also be noted that complex
CABG techniques, expected to decrease stroke incidence (eg,
off-pump CABG, anaortic CABG), might act as confounders for
surgeons who are more skilled or who have a wider variety of
techniques in their armamentarium.
Continuous monitoring of cerebral perfusion may allow
optimization of cerebral perfusion pressure and reduce the
incidence of watershed infarction.70
Regarding salvage strategies for stroke following CABG,
given the contraindication to systemic ﬁbrinolysis because of
the high risk of hemorrhage, currently available alternative
techniques entail intra-arterial ﬁbrinolysis and mechanical
thrombectomy, with the latter associated with higher recanal-
ization rates (63.2% versus 83.6% for intra-arterial ﬁbrinolysis
versus mechanical thrombectomy, respectively; P<0.01).71 Of
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note, an important factor in mechanical thrombectomy is
timing; the procedure should be performed in the ﬁrst 6 hours
after the onset of symptoms. A number of devices are
available, including retrieval stents that are deployed within
the thrombus, incorporating and then removing it; memory-
shaped nitinol wires that are advanced in the thrombus to
engage and remove it; and aspiration devices designed to
aspirate the thrombus from larger vessels.72
DAPT after CABG does not appear to reduce the risk of
recurrent stroke. A recent analysis of CABG patients in the
FREEDOM (Future Revascularization Evaluation in Patients with
Diabetes Mellitus: Optimal Management of Multivessel Dis-
ease) trial found the rate of stroke to be similar at 5 years in
patients who were discharged on DAPT versus aspirin only (HR:
0.85; 95% CI, 0.36–1.99),73 and a meta-analysis conﬁrmed this
ﬁnding.74 Ongoing randomized trials will shed more light on the
relative risks and beneﬁts of prolonged DAPT after CABG. In
patients with POAF, guidelines recommend anticoagulation
with unfractionated or low-molecular-weight heparin if POAF
persists 12 to 48 hours and anticoagulation therapy for at least
4 weeks if POAF persists at discharge.75
Of note, in contemporary RCTs, the use of optimal medical
therapy is lower after CABG than after PCI and correlates with
a composite of adverse follow-up clinical outcomes including
death, myocardial infarction, and stroke.76
Percutaneous Coronary Intervention
In a meta-analysis of 22 843 patients, compared with femoral
access, radial access reduced mortality, major adverse
ischemic events, and major bleeding across the spectrum of
patients with coronary artery disease. Nevertheless, no
differences were noted in rates of stroke between radial
and femoral approaches.77 However, recent results of a large
prospective Japanese registry of 17 966 patients undergoing
PCI showed that, compared with transfemoral procedures,
transradial interventions were associated with reduced risk of
periprocedural stroke. This ﬁnding was conﬁrmed using both
multivariable logistic regression (OR: 0.33; 95% CI, 0.16–0.71;
P=0.004) and propensity score matching (0.1% versus 0.4%;
P=0.01) analysis.78 In another meta-analysis of 6450 patients
from 12 trials, no signiﬁcant differences in stroke rates were
noted between right and left radial accesses.79 However,
operator experience with catheter manipulation along the
aortic wall, which can lead to embolization, may play a role in
stroke risk, and the use of a transradial approach must be
considered as a surrogate for operator experience.
Effective anticoagulation is key to avoid thrombus
formation during PCI. Current guidelines recommend a 70-
to 100-U/kg intravenous bolus of unfractionated heparin
when no glycoprotein IIb/IIIa inhibitor is planned and a 50- to
70-U/kg intravenous bolus with glycoprotein IIb/IIIa
inhibitors.33 Full-dose unfractionated heparin should be also
administered to patients with non–ST-segment–elevation ACS
undergoing cardiac catheterization after a conservative treat-
ment phase if they were treated with fondaparinux because of
the increased risk of catheter thrombosis compared with
heparin.80 Alternatively, bivalirudin may be used for procedu-
ral anticoagulation. Because of the high rates of catheter
thrombosis, fondaparinux is contraindicated in patients with
ST-segment–elevation myocardial infarction undergoing pri-
mary PCI.81,82 No differences in stroke were reported in trials
and meta-analyses of bivalirudin versus heparin.83–86
The combination of aspirin and P2Y12 inhibitors is the
standard of care after PCI. Although trials of DAPT have
generally been powered to assess the impact on a combined
ischemic end point (cardiovascular death, myocardial infarc-
tion, and stroke) and not for stroke alone, by acting on the
platelet-mediated process of thrombus formation DAPT may
also affect cerebrovascular ischemic event rates.87,88 DAPT
with aspirin and clopidogrel is the standard of care for PCI in
patients with stable coronary artery disease, whereas the
combination of aspirin with clopidogrel, prasugrel, or ticagrelor
is the recommended standard of care for PCI in patients with
ACS.89 However, the use of prasugrel or ticagrelor has not been
shown to reduce the risk of stroke compared with clopidogrel in
pivotal regulatory trials of PCI in ACS.90–92 Importantly,
prasugrel may increase the risk of fatal and intracranial
bleeding in patients with prior stroke or transient ischemic
attack, representing an absolute contraindication for its use.90
Special considerations apply to patients with ST-segment–
elevationmyocardial infarction, where there is a decrease in the
incidence of stroke after primary PCI compared with rescue or
facilitated PCI after thrombolysis. In the TOTAL (Thrombectomy
with PCI vs. PCI Alone in patients with STEMI) trial, the risk of
stroke after thrombus aspiration during primary PCI was
increased, and current guidelines contraindicate the routine
use of thrombus aspiration.33,81 The routine use of IABP,
including use in patients with acute myocardial infarction
complicated by cardiogenic shock, is also not recom-
mended.33,93 Limited data exist on cerebral embolic protective
devices for both PCI and CABG to prevent the risk of stroke.
Practical Implications
Stroke carries high short- and long-term mortality and
signiﬁcantly adversely affects quality of life after both CABG
and PCI. In an era in which practice guidelines endorse fully
informing patients of the available treatment options and
actively including them in the decision-making process,
deﬁning the risk of stroke, both acute and long term, and
its clinical implications is of paramount importance. CABG
carries higher perioperative risk of stroke but provides greater
long-term freedom from recurrent ischemic coronary events
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and better survival, especially in the patients with most severe
disease.2 Percutaneous revascularization is feasible in many
patients and is associated with relatively low stroke rates, but
this beneﬁt needs to weighed against the higher rates of long-
term mortality and myocardial infarction, particularly in some
categories of patients with diabetes mellitus and/or extensive
multivessel disease. Indeed, better understanding the size of
an injury deriving from a stroke with the 2 available
revascularization approaches and the signiﬁcance of silent
brain lesions or neurocognitive changes that may occur would
inform the decision-making process. However, data on these
measures (eg, serial brain imaging) are lacking.
A number of measures can be considered to reduce
neurological risk in patients undergoing revascularization. For
surgery, pre- and intraoperative screening of the ascending
aorta and optimization of cerebral perfusion pressure based on
continuous monitoring are important measures to minimize
stroke risk. The use of the anaortic technique has the potential
to minimize stroke risk during CABG. Given its technical
complexity, speciﬁc training is required, ideally in the context of
a new CABG subspecialty. Other technical advancements (eg,
embolic protection) warrant investigation to reduce the
perioperative risk of stroke in patients undergoing CABG.
For PCI, the reduction in mortality and bleeding—with some
data also showing a reduction in periprocedural stroke—
associated with radial access potentially makes this approach
the vascular access of choice. Regardless of vascular access,
operator experience and competency play key roles in
minimizing catheter-induced trauma to the aortic wall and
cerebral embolization. Other important measures include
optimal anticoagulation and avoidance of air embolism with
adequate ﬂushing and connections to themanifold. Routine use
of manual thrombectomy in ST-segment–elevation myocardial
infarction should be avoided; if required, adequate catheter
engagement should be maintained to avoid embolization of
thrombotic material. Finally, IABP and hemodynamic support
devices in general should be used with caution, particularly in
patients with diffuse atherosclerotic aortic disease.
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